BIOMILQ

company

About

BIOMILQ leverages breakthrough mammary biotechnology to produce human milk outside of the body to nourish a world to its full potential.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
$21M
Industries
AgTech,Baby,Biotechnology,Food and Beverage
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

We leverage our patent-pending technology to produce nutritionally equivalent breastmilk from cultured human mammary cells. With Biomilq, families can achieve the recommended six months of exclusive breastfeeding while alleviating the climate impacts of bovine-based infant formula.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$21M
BIOMILQ has raised a total of $21M in funding over 2 rounds. Their latest funding was raised on Oct 20, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 20, 2021 Series A $21M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
BIOMILQ is funded by 1 investors. Gaingels are the most recent investors.
Investor Name Lead Investor Funding Round
Gaingels Series A